Back to mobile site

More on XERS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+200.0% Growth)
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xeris Pharmaceuticals Inc. (NQ:XERS)
Delayed: 6.95 +0.05 (0.72%)
Prev. Close $6.90  
Open$7.03 
52 Wk High$ 
52 Wk Low$ 
Day High$7.06 
Day Low$6.93 
P/E N/A  
EPS$ 
Volume2,398,786 

Friends, Peers and Foes (?): VRNA, ANAB, DSGN, HLXA PSTX (more...)

Jun 11, 2026 04:39 PM NASDAQ: XERS receives patent allowance for KEVEYIS extending protection to 2039
Jun 11, 2026 04:39 PM Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS®
Jun 11, 2026 07:16 AM Form 8-K Xeris Biopharma Holdings For: Jun 10
Jun 11, 2026 07:00 AM Xeris Biopharma exchanges $23 million in convertible notes for cash and stock
Jun 11, 2026 07:00 AM Xeris Biopharma Announces Private Exchange of Convertible Notes
Jun 5, 2026 06:40 PM Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: Kong Garheng
Jun 5, 2026 06:29 PM Form 4 Xeris Biopharma Holdings For: Jun 03 Filed by: PERSKY MARLA
Jun 5, 2026 06:18 PM Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: HALKUFF DAWN
Jun 5, 2026 06:18 PM Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: BORMANN-KENNEDY BARBARA-JEAN ANNE
Jun 5, 2026 06:18 PM Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: JOHNSON JOHN
View All Articles

Entities mentioned with XERS

View All Entities